EvolveImmune Therapeutics Employee Directory
Biotechnology ResearchConnecticut, United States51-200 Employees
EvolveImmune is pioneering a pipeline of unique trispecific T cell engagers with integrated CD2 costimulation. The EVOLVE platform tackles the treatment challenges of cancer cell resistance to current immunotherapies. The company’s lead internal drug candidate, EVOLVE104, will enter the clinic in 2025. We are based in Branford, CT.